Back to
NORTHERN TRUST CORP
IKT7 quarters
Position history for
NORTHERN TRUST CORP's holdings in INHIBIKASE THERAPEUTICS INC
Yes. Northern Trust holds 878,585 shares of IKT (Inhibikase Therapeutics), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 159,785 shares (+22.2%) from Q1 2026. Northern Trust has held IKT since Q4 2024, across 7 quarterly 13F filings.
Current Value
$1.8M
Current Shares
878,585
Total Value Change
+$1.6M
Total Shares Change
+814,574
Quarter-by-Quarter History
Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC